Skip to main content
SpringerLink
Log in
Book cover

Urinzytologie und Sedimentanalyse pp 1–6Cite as

Indikationen zur Urinzytologie

  • Chapter

  • 1382 Accesses

Zusammenfassung

Die Krebsstatistiken nicht nur der industrialisierten Regionen belegen eine weiter zunehmende Inzidenz urothelialer Tumoren.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

Zitierte Literatur

  • Althausen AF, Prout GR, Daly JJ (1976) Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 116: 575

    Google Scholar 

  • Bansidar BJ (2012) Extracolonic manifestations of Lynch Syndrome. Clin Colon Rectal Surg 25: 103-110

    Google Scholar 

  • Berufsgenossenschaftliche Grundsätze für arbeitsmedizinische Vorsorgeuntersuchungen, 2. Ausg. (1981) Genter, Stuttgart

    Google Scholar 

  • Bretton PR, Herr HW, Kimmel M, Fair WR, Whitemore WF jr., Melamed MR (1989) Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus calmette-guerin. J Urol 141: 1332

    Google Scholar 

  • Cordonnier JJ, Spjut HJ (1962) Urethral occurrence of bladder carcinoma following cystectomy. J Urol 87: 398

    Google Scholar 

  • Esposti PL, Edsmyr B, Tribukait B (1978) The role of exfoliative cytology in the management of bladder carcinoma. Urol Res 6: 197

    Google Scholar 

  • Gowing NFC (1960) Urethral carcinoma associated with cancer of the bladder. Br J Urol 32: 428

    Google Scholar 

  • Harving N, Wolf H, Melsen F (1988) Positive urinary cytology after tumor resection: an indicator for concomitant carcinoma in situ. J Urol 140: 495

    Google Scholar 

  • Hermansen DK, Badalament RA, Whitemore WF jr., Fair WF, Melamed MR (1988) Detection of carcinoma in the post-cystectomy urethral remnant by flow cytometric analysis. J Urol 139: 304

    Google Scholar 

  • Hickey DP, Soloway MS, Murphy WM (1986) Selective urethrectomy following cystprostatectomy for bladder cancer. J Urol 136: 828

    Google Scholar 

  • Jakse G, Hufnagel B, Hofstädter F, Rübben H (1986) Sequentielle Blasenschleimhautbiopsie beim Urothelkarzinom der Harnblase. Verh Dtsch Ges Urol 37: 200

    Google Scholar 

  • Koss LG, Deitch D, Ramanthan R, Sherman AB (1985) Diagnostic value of cytology of voided urine. Acta Cytol 29: 810

    Google Scholar 

  • Koss LG, Melamed MR, Kelly RE (1969) Further cytologic and histologic studies of bladder lesions in workers exposed to paraaminodiphenyl: progress report. J Nat Cancer Inst 43: 233

    Google Scholar 

  • Koss LG, Melamed MR (Edit) (2006) Koss’ Diagnostic Cytology and its histopathological Bases. Lippincott Williams and Wilkins, Philadelphia (ISBN 0-7817-1928-3)

    Google Scholar 

  • Koss LG, Melamed MR, Kelly RE (1969) Further cytologic and histologic studies of bladder lesions in workers exposed to paraaminodiphenyl: progress report. J Nat Cancer Inst 43: 233

    Google Scholar 

  • Müller F, Kraft R, Zingg E (1985) Exfoliative cytology after transurethral resection of superficial bladder tumors. BrJ Urol 57: 530

    Google Scholar 

  • Murphy WM (2006) What’s the trouble with cytology? J urol 176: 2343–2346

    Google Scholar 

  • Murphy WM, Emerson LD, Chandler RW, Moinuddin SM, Soloway MS (1986) Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. J Urol 136: 815

    Google Scholar 

  • Porpaczy P, Schramek P (1981) Analgesic nephropathy and phenacetin-induced transitional cell carcinoma - Analysis of 300 patients with long-term comsumption of phenacetin-containing drugs. Eur Urol 7: 349

    Google Scholar 

  • Rathert P (1987) Paracetamol. Dtsch Med Wochenschr 112: 40

    Google Scholar 

  • Rathert P, Melchior HJ, Lutzeyer W (1975) Phenacetin: A carcinogen for the urinary tract? J Urol 113: 653

    Google Scholar 

  • Roth St, Rathert P (1988) Vesiko-enterale Fisteln: Lösungswege eines diagnostischen Dilemmas. Urologe [A] 27: 142

    Google Scholar 

  • Roth St, Rathert P (1989) Cytological surveillance of carcinoma in situ during and after intravesikal chemotherapy. In: Therapeutic Progress in Urological Cancers. Liss, New York, p 523

    Google Scholar 

  • Rübben H, Rathert P, Roth St, Hofstädter F, Giani G, Terhorst B, Friedrichs R (1989) Exfoliative Urinzytologie. Harnwegstumorregister, 4. Aufl. Fort- und Weiterbildungskommission der Deutschen Urologen, Arbeitskreis Onkologie, Sektion Urinzytologie

    Google Scholar 

  • Schellhammer PF, Whitemore WF jr. (1976) Transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer. J Urol 115: 56

    Google Scholar 

  • Seitz M, Zaak D, Knüchel-Clarke R, Stief C (2005) Harnblasentumoren. Die neue WHO-Klassifikation 2004. Urologe 44: 1073–1086

    Google Scholar 

Weiterführende Literatur

  • Götz M et al. (2014) Fall K.Z. Kongress DGU 2014. P.1.23

    Google Scholar 

  • Hiroki I, Kikuchi E, Shinodak, Mukai M, Murai M (2007) Carcinoma in situ developing in an ileal neobladder. Urology 69: 576

    Google Scholar 

  • IARC, Internationale Agentur für Krebsforschung (WHO), Gruppe 1-3

    Google Scholar 

  • North AC, Lakshmanan Y (2007) Malignancy associated with the use of intestinal segments in the urinary tract. Urol Oncol. 25(2): 165–167

    Google Scholar 

  • Retz M, Gschwend JE, Maisch P (2016) Kurzform der S3-Leitlinie Harnblasenkarzinom. Urologe 55: 1173–1187

    Google Scholar 

  • Steinke V et al. (2013) Hereditary Nonpolyposis Colorectal Cancer (HNPCC)/Lynch Syndrome. Dtsch Arztebl Int 110(3): 32–38

    Google Scholar 

  • Suriano F, Altobelli E, Sergi F, Buscar M (2013) Bladder cancer after radiotherapy for prostate cancer. Rev Urol 15:108–112

    Google Scholar 

  • Tolkach Y, Kristiansen G (2017) Pathogense urologischer Komplikationen nach Strahlentherapie. Urologe 56: 293–300

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Urinzytologie, Rheinort 5, 40213, Düsseldorf, Deutschland

    Prof. Dr. med. Peter Rathert

  2. Lehrstuhl für Urologie der Universität Witten/Herdecke, Helios Kliniken Wuppertal, Direktor der Klinik für Urologie und Kinderurologie, Heusnerstr. 40, 42283, Wuppertal, Deutschland

    Prof. Dr. med. Stephan Roth

Authors
  1. Prof. Dr. med. Peter Rathert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Stephan Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Peter Rathert or Stephan Roth .

Editor information

Editors and Affiliations

  1. Institut für Urinzytologie, Düsseldorf, Deutschland

    Peter Rathert

  2. HELIOS Klinikum, Wuppertal, Deutschland

    Stephan Roth

  3. Universitätsklinikum Rostock, Urologische Klinik/Poliklinik, Rostock, Deutschland

    Oliver Hakenberg

  4. Wiesloch, Deutschland

    Josefine Neuendorf

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Rathert, P., Roth, S. (2018). Indikationen zur Urinzytologie. In: Rathert, P., Roth, S., Hakenberg, O., Neuendorf, J. (eds) Urinzytologie und Sedimentanalyse. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55660-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-55660-3_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-55659-7

  • Online ISBN: 978-3-662-55660-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation